Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Dem Biopharma, Inc.

Clinical trials sponsored by Dem Biopharma, Inc., explained in plain language.

Not yet recruiting 1

Can a targeted drug conjugate outsmart advanced colorectal cancer?

Disease control Not yet recruiting

This phase 1 trial tests an investigational drug called DEM301 in adults with advanced colorectal cancer that has progressed after standard treatments. DEM301 is an antibody-drug conjugate, a type of therapy designed to deliver a toxic agent directly to cancer cells. The study ai…

Phase 1 • Sponsor: DEM BioPharma, Inc. • Aim: Disease control

Last updated Sep 11, 2026 00:00 UTC